Table II.

Pathogen and stage I surgery.

Case	Type of stage 1 surgery	Pathogen	Antibiotics administration after stage 1 (IV)	Length of antibiotic therapy after stage 1 (weeks)	Interval to normal CRP (weeks)	Interval to THA (months)
1	Girdlestone	Burkholderia pseudomallei	Meropenem Ceftazidime	L-24	L-12	L-12
				R-10	R-7	R-9.5
2	Girdlestone	Stenotrophomonas maltophilia	Meropenem	12	12	33
3	Girdlestone	Escherichia coli	Levofloxacin	8	6	69
4	Girdlestone	MRSA	Vancomycin	6	5	24
5	Spacer	Enterobacter cloacae	Meropenem	6	4	3
6	Spacer	Corynebacterium	Vancomycin meropenem Cefoperazone	8	6	5.5
7	Spacer	Negative	Vancomycin moxifloxacin	8	4	4.5
8	Spacer	Streptococcus	Vancomycin levofloxacin	8	4	3
9	Spacer	MSSA	Vancomycin cefuroxime	6	4	4
10	Spacer	Negative	Vancomycin levofloxacin	12	12	3
11	Spacer	MRSA	Vancomycinlinezolid	12	10	3
12	Spacer	MSSA	Vancomycin	6	3	4
13	Spacer	MSSA	Vancomycin	6	5	6

L, left; R, right; CRP, C-reactive protein; THA, total hip arthroplasty; MRSA, Methicillin-resistant Staphylococcus aureus; MSSA, Methicillin-susceptible Staphylococcus aureus.